Grandeur Peak Global Advisors’s Cipher Pharmaceuticals Inc. CPHR Stock Holding History

Grandeur Peak Global Advisors’s Portfolio CPHR Stock Details CPHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-1,941,100	Closed	-$8.53M	–	109
2017 Q2	$8.53M	Sell	1,941,100 -159,500	-8%	-$701K	1.23%	25
2017 Q1	$7.26M	Hold	2,100,600	–	–	1.19%	29
2016 Q4	$7.65M	Sell	2,100,600 -33,600	-2%	-$110K	1.4%	24
2016 Q3	$8.13M	Sell	2,134,200 -32,900	-2%	-$150K	1.58%	23
2016 Q2	$11.3M	Sell	2,167,100 -81,300	-4%	-$463K	2.43%	9
2016 Q1	$10.8M	Buy	2,248,400 +153,200	+7%	+$673K	2.16%	11
2015 Q4	$9.83M	Buy	2,095,200 +588,600	+39%	+$2.55M	2.03%	12
2015 Q3	$5.57M	Buy	1,506,600 +382,500	+34%	+$2.66M	1.24%	29
2015 Q2	$9.61M	Buy	1,124,100 +1,099,400	+4,451%	+$11M	1.89%	11
2015 Q1	$223K	Buy	24,700 +3,700	+18%	+$46.5K	0.05%	101
2014 Q4	$303K	Buy	+21,000	New	+$305K	0.07%	97

Grandeur Peak Global Advisors's CPHR Position: Q3 2017 in Review

Grandeur Peak Global Advisors sold out of Cipher Pharmaceuticals Inc. (CPHR) in Q3 2017, closing a stake of 1,941,100 shares — an estimated $8.53M sold.

Grandeur Peak Global Advisors first reported a position in CPHR in Q4 2014 and held it in 11 quarters. The position peaked at $11.3M in Q2 2016. 0 funds tracked by Wall St. Rank hold CPHR as of Q3 2017.

Grandeur Peak Global Advisors reported no remaining Cipher Pharmaceuticals Inc. position as of Q3 2017 after selling out during the quarter.
Grandeur Peak Global Advisors sold 1,941,100 Cipher Pharmaceuticals Inc. shares in Q3 2017, an estimated $8.53M.
Grandeur Peak Global Advisors first reported a position in Cipher Pharmaceuticals Inc. in Q4 2014 and held it in 11 quarters.
Grandeur Peak Global Advisors's Cipher Pharmaceuticals Inc. position peaked at $11.3M in Q2 2016.
0 funds tracked by Wall St. Rank held Cipher Pharmaceuticals Inc. as of Q3 2017.

Based on Grandeur Peak Global Advisors's 13F filing for Q3 2017, filed 14 Nov 2017.